Learning Objectives:

  1. To understand the clinical utility of “liquid biopsy” in patients with Multiple Myeloma
  2. To define cellular states in Multiple Myeloma patients and how they change with treatment
  3. To identify potential treatment strategies in therapy-resistant Multiple Myeloma
Session date: 
01/27/2020 - 12:00pm to 1:00pm CST
900 East 57th Street
KCBD Auditorium 1103
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Jens G. Lohr, MD, PhD